Zhuhai Trinomab Pharmaceutical Co., Ltd. (SHA:688806)
China flag China · Delayed Price · Currency is CNY
25.90
+2.06 (8.64%)
At close: Aug 4, 2026

SHA:688806 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Equivalents
475.3515.37559.41594.72758.35
Short-Term Investments
---30.81-
Cash & Short-Term Investments
475.3515.37559.41625.53758.35
Cash Growth
-37.33%-7.87%-10.57%-17.51%-
Accounts Receivable
6683.14--16.31
Other Receivables
3.13.012.381.681.61
Receivables
69.0986.152.381.6817.92
Inventory
103.4895.1657.5325.0823.18
Other Current Assets
61.8341.959.6211.5432.03
Total Current Assets
709.7738.63628.96663.82831.47
Property, Plant & Equipment
186.2190.42219.13230.81215.27
Long-Term Investments
--12.2111-
Other Intangible Assets
4.955.362.863.53.61
Long-Term Deferred Charges
12.6515.3635.3664.3989.13
Other Long-Term Assets
20.328.7234.7818.4111.97
Total Assets
933.8978.5933.3991.931,151

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22
Accounts Payable
15.4735.6593.2128.9335.37
Accrued Expenses
40.8451.5329.2922.7117.88
Short-Term Debt
46.9967.0171.1928.0330.03
Current Portion of Long-Term Debt
251.39216.7164.32.9719.29
Current Portion of Leases
11.311.4712.659.6214.01
Current Income Taxes Payable
----0
Current Unearned Revenue
45.4758.77817.629.9
Other Current Liabilities
15.6611.656.736.737.85
Total Current Liabilities
427.12452.79285.38116.61134.33
Long-Term Debt
432.76363.74208.15111.5932.01
Long-Term Leases
37.5336.9745.9851.4224.15
Long-Term Unearned Revenue
8.929.3410.74--
Total Liabilities
906.33862.84550.25279.63190.49

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22
Common Stock
391.46391.46371.2360148.62
Additional Paid-In Capital
1,1701,162859.5685.231,896
Retained Earnings
-1,545-1,449-847.7-332.93-1,083
Comprehensive Income & Other
-0.69-0.490.050-0.02
Total Common Equity
15.79103.66383.05712.3960.96
Minority Interest
11.6812.01---0
Shareholders' Equity
27.47115.66383.05712.3960.96
Total Liabilities & Equity
933.8978.5933.3991.931,151

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22
Total Debt
779.97695.91402.27203.64119.5
Net Cash (Debt)
-304.67-180.53157.14421.9638.86
Net Cash Growth
---62.75%-33.96%-
Net Cash Per Share
-0.78-0.470.431.343.99
Filing Date Shares Outstanding
391.46391.46371.2314.41159.95
Total Common Shares Outstanding
391.46391.46371.2314.41159.95
Working Capital
282.59285.84343.58547.21697.14
Book Value Per Share
0.040.261.032.276.01
Tangible Book Value
10.8498.29380.18708.8957.36
Tangible Book Value Per Share
0.030.251.022.255.99
Machinery
243242.09236.55215.04205.79
Construction In Progress
1.741.491.728.575.42